BioXcel Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 233428000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | current |
| Entity | BioXcel Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/88605e37-eb20-40f1-b581-fcf56f3e37ac
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-013632Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001720893/cash-and-equivalents/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/88605e37-eb20-40f1-b581-fcf56f3e37ac
History
- no predecessors — first report